Yoonyeong Choi

Dr. Yoonyeong Choi

orcid

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2024 in Journal of the Korean Society of Radiology
Verified
Journal Article
Open access
PDF file
YCYoonyeong Choi
Yoonyeong Choi
HLHa Young Lee
Ha Young Lee
MLMyung Kwan Lim
Myung Kwan Lim
YKYoung Hye Kang
Young Hye Kang
최윤영, et al. J Korean Soc Radiol. 2024 May;85:e53. https://doi.org/10.3348/jksr.2023.0023

1 January 2025 in Journal of the Korean Society of Radiology
Verified
Journal Article
Open access
PDF file
KLKyeong Jin Lee
Kyeong Jin Lee
YCYoonyeong Choi
Yoonyeong Choi
SCSuk Jin Choi
Suk Jin Choi
MBMin Sun Bae
Min Sun Bae
이경진, et al. J Korean Soc Radiol. 2025 Jan;86:e2. https://doi.org/10.3348/jksr.2024.0093

1 January 2023 in Investigative Magnetic Resonance Imaging
Verified
Journal Article
Open access
PDF file
YCYoonyeong Choi
Yoonyeong Choi
RLRo Woon Lee
Ro Woon Lee
KLKyu Hong Lee
Kyu Hong Lee
YYYong Han Yoon
Yong Han Yoon
Choi YY, et al. Investig Magn Reson Imaging. 2023 Jun;27(2):114-119. https://doi.org/10.13104/imri.2023.0001

30 January 2026 in Tomography
Verified
Journal Article
Open access
PDF file
SSSung Ui Shin
Sung Ui Shin
MJMijung Jang
Mijung Jang
BYBo La Yun
Bo La Yun
SCSu Min Cho
Su Min Cho
YCYoonyeong Choi
Yoonyeong Choi
SKSun Mi Kim
Sun Mi Kim
Background/Objectives: We compared the visibility of breast cancer using the newly developed standing automated breast ultrasound system (MammouS-N) and digital breast tomosynthesis (DBT), and identified factors influencing lesion visibility. Methods: We prospectively enrolled 100 women (mean age: 51.6 years; range: 26–76 years) who were diagnosed with breast cancer and were scheduled to undergo DBT between January and July 2024. They underwent DBT and an ultrasound on the same day. Two radiologists evaluated the visibility scores (0–5) of lesions corresponding to biopsy-confirmed breast cancers identified using magnetic resonance imaging. The Wilcoxon signed-rank test was used to compare the visibility scores of cancers identified on DBT and/or MammouS-N images. Results: Among the 100 women, invasive ductal carcinoma was the most common malignancy (73%). DBT findings included negative findings (7%), masses (46%), masses with calcification (29%), calcifications only (15%), and architectural distortions (3%). On MammouS-N ultrasound, most lesions were classified as masses (93%), whereas 7% were non-mass lesions. For Reviewer 1, MammouS-N demonstrated significantly higher visibility scores (higher scores: 26 on MammouS-N, seven on DBT; equal scores: 67, z = −3.234, p = 0.001). For Reviewer 2, the two modalities showed no significant difference in visibility (higher scores: 27 on MammouS-N, 28 on DBT, equal scores: 45, z = −0.040, p = 0.968). Noncalcified lesions that were obscured on DBT were better visualized on MammouS-N (p < 0.001) by both reviewers. Conclusions: MammouS-N holds promise as an imaging modality complementary to DBT in women with dense breast tissue, particularly for non-calcified lesion detection.

5 December 2025 in Tomography
Verified
Journal Article
Open access
PDF file
BYBo La Yun
Bo La Yun
SKSun Mi Kim
Sun Mi Kim
SSSung Ui Shin
Sung Ui Shin
SCSu Min Cho
Su Min Cho
YCYoonyeong Choi
Yoonyeong Choi
MJMijung Jang
Mijung Jang
Background/Objectives: To identify preoperative MRI features using computer-assisted diagnosis (CAD) that are associated with invasive disease-free survival (IDFS) and distant metastasis-free survival (DDFS) in patients with primarily operable triple-negative breast cancer (TNBC). Methods: This retrospective study was approved by the institutional review board with informed consent was waived. Between January 2012 and December 2014, 74 consecutive women with primary TNBC (mean age, 51 years; range, 29–77 years) who underwent preoperative MRI were included and followed until August 2021. Dynamic contrast-enhanced and T2-weighted images were obtained using 3T scanners. Peritumoral edema and central necrosis were evaluated retrospectively. CAD was used to extract 3D diameters, angiovolume, and kinetic parameters, and kinetic heterogeneity was calculated. Cox proportional hazards models were used to assess associations between MRI features and IDFS and DDFS, adjusting for clinicopathologic factors. Results: During a median follow-up of 80.9 months, 12 patients developed invasive disease, and 8 developed distant metastasis. In multivariable analysis, peak enhancement (hazard ratio [HR], 1.40; 95% confidence interval [CI], 1.06–1.84; p = 0.019) and angiovolume (HR, 2.86; 95% CI, 1.26–6.47; p = 0.012) were independently associated with IDFS, whereas angiovolume (HR, 2.47; 95% CI: 1.28–4.78; p = 0.007) was independently associated with DDFS. Conclusions: Preoperative CAD-derived MRI features, particularly peak enhancement and angiovolume, were associated with IDFS in TNBC patients whereas angiovolume alone was associated with DDFS.